---
figid: PMC3579607__onc0011311900001
figtitle: Mechanisms underlying HER2-directed therapy cardiotoxicity
organisms:
- Homo sapiens
pmcid: PMC3579607
filename: onc0011311900001.jpg
figlink: /pmc/articles/PMC3579607/figure/F1/
number: F1
caption: 'Mechanisms underlying HER2-directed therapy cardiotoxicity. Inhibition of
  ErbB receptors with HER2-directed therapies impacts numerous signaling pathways
  resulting in suppression of myofilament protein synthesis via the PI3K-Akt pathway
  (pathway A), suppression of protein hypertrophy via the MAPK pathway (pathway B),
  suppression of cell survival via Src/Fak pathway (pathway C), suppression of myofilament
  protein synthesis and upregulation of protein degradation via TGF-β1 and C/EBPβ
  signaling (pathway D), and alterations in cardiac energy metabolism via downregulation
  of AMPK (pathway E).Abbreviations: AMPK, AMP-activated protein kinase; C/EBPβ, CCAAT/enhancer
  binding protein; Fak, focal adhesion kinase; MAPK, mitogen-activated protein kinase;
  Nrg1, Neuregulin-1β; PI3K, phosphatidylinositol 3-kinase; Smad, small mother against
  decapentaplegic; TGFβ, transforming growth factor β.'
papertitle: The Potential Role of Aerobic Exercise to Modulate Cardiotoxicity of Molecularly
  Targeted Cancer Therapeutics.
reftext: Jessica M. Scott, et al. Oncologist. 2013 Feb;18(2):221-231.
year: '2013'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9733164
figid_alias: PMC3579607__F1
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC3579607__F1
ndex: ca13100b-dec2-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3579607__onc0011311900001.html
  '@type': Dataset
  description: 'Mechanisms underlying HER2-directed therapy cardiotoxicity. Inhibition
    of ErbB receptors with HER2-directed therapies impacts numerous signaling pathways
    resulting in suppression of myofilament protein synthesis via the PI3K-Akt pathway
    (pathway A), suppression of protein hypertrophy via the MAPK pathway (pathway
    B), suppression of cell survival via Src/Fak pathway (pathway C), suppression
    of myofilament protein synthesis and upregulation of protein degradation via TGF-β1
    and C/EBPβ signaling (pathway D), and alterations in cardiac energy metabolism
    via downregulation of AMPK (pathway E).Abbreviations: AMPK, AMP-activated protein
    kinase; C/EBPβ, CCAAT/enhancer binding protein; Fak, focal adhesion kinase; MAPK,
    mitogen-activated protein kinase; Nrg1, Neuregulin-1β; PI3K, phosphatidylinositol
    3-kinase; Smad, small mother against decapentaplegic; TGFβ, transforming growth
    factor β.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ERBB4
  - ERBB2
  - ERBB3
  - NRG1
  - TGFB1
  - TGFB2
  - TGFB3
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - IARS1
  - IRS1
  - IRS2
  - IRS4
  - SRC
  - FGR
  - FYN
  - YES1
  - PDK1
  - PDPK1
  - ATP8A2
  - APRT
  - MFAP1
  - SMAD1
  - SMAD4
  - SMAD5
  - SMAD6
  - SMAD7
  - SMAD9
  - SMAD2
  - SMAD3
  - PTK2
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - AKT1
  - AKT2
  - AKT3
  - FOXO1
  - FOXO3
  - FOXO4
  - FOXO6
  - MTOR
  - CRTC1
  - CELF1
  - EIF4EBP1
  - FBXO32
  - TRIM63
  - RPS6KB1
  - CEBPB
  - SMG1
  - GATA4
  - Cancer
---
